Interview with Tree Frog Therapeutics – Alasdair Thong March 16, 2021 by Selvedge Venture with no comment Team Interview with Tree Frog Therapeutics:Stem cell therapies from an investor perspective – Alasdair Thong, Early Stage Healthcare Investor Previous Post Mesh Bio raises US$1.8M seed to help doctors predict diseases before they occur Next Post Healthtech startup Mesh Bio in Singapore raises $1.8 M in seed funding